Skip to main content

Table 2 Classification of endometrial cancer cell lines into four groups

From: Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

Groups

Cell line

PIK3CA

KRAS

PTEN

PIK3R1

PIK3R2

PTEN expression

Group 1 (PIK3CA-mutated only)

SKUT2

E545K (hetero)

Wild-type

Wild-type

Wild-type

Wild-type

High

MFE280

H1047Y (hetero)

Wild-type

Wild-type

Wild-type

Wild-type

High

Group 2a (PTEN-mutated, PTEN-retained)

EN1078D

Wild-type

Wild-type

Y88C

G376R (hetero)

Wild-type

High

MFE296

P539R (hetero); I20M (hetero)

Wild-type

R130Q (homo); N322 fs (hetero)

Wild-type

Wild-type

High

ETN1

Wild-type

Wild-type

I122V (hetero), R130L (hetero); N328 fs (hetero)

Wild-type

Wild-type

High

Group 2b (PTEN-mutated and PTEN-Loss)

AN3CA

Wild-type

Wild-type

R130fs (homo)

REID557del (hetero)

Wild-type

Low

HEC59

Wild-type

Wild-type

Y46H (hetero); R233 (hetero); P246L (hetero)

T473S (hetero); K567E (hetero); S460 fs (hetero)

Wild-type

Low

EN

T1025A (hetero)

Wild-type

K266 fs (hetero)

N260S (hetero)

Wild-type

Low

Group 3 (KRAS-mutated)

HEC1A

G1049R (hetero)

G12D (homo)

Wild-type

Wild-type

Wild-type

High

HEC1B

G1049R (hetero)

G12D (homo)

Wild-type

Wild-type

Wild-type

High

HEC50

Wild-type

G12D (hetero)

Wild-type

E468InsGEYDRLYE (homo)

Wild-type

High

Group 4 (Wild-type)

EFE184

Wild-type

Wild-type

Wild-type

Wild-type

Wild-type

High

KLE

Wild-type

Wild-type

Wild-type

Wild-type

Wild-type

High

  1. The 6 cell lines highlighted in bold were selected for further RPPA analyses